Drug Designing: Open Access
Open Access

2^nd International Conference and Expo on Drug Discovery & Designing

October 27-29, 2016 Rome, Italy

Scientific Tracks Abstracts

• Novel enzyme therapies for treatment of Cocaine addiction and overdose

  Fang Zheng and Chang-Guo Zhan

  PDF HTML

• Treating Alzheimers disease model mice with traditional chinese medicine

  Qiang Zhou

  PDF HTML

• Targeting the toxic oligomers of amyloidogenic proteins by self-assembled cyclic D, L-α-peptides: Potential application for Alzheimers and Parkinsons diseases

  Shai Rahimipour, Marina Chemerovski-Glikman and Michal Richman

  PDF HTML

• Assessment of mucoadhesion properties of different polymers and mucosal tissues by texture analyzer

  Fatmanur Tugcu-Demiroz, Serdar Tort, Sibel Ilbasmis-Tamer and Fusun Acarturk

  PDF HTML

• Smart drug delivery systems targeted delivery of chemotherapeutics, immunostimulators and siRNA molecules

  Gozde Unsoy and Ufuk Gunduz

  PDF HTML

• Development and evaluation of lipid-polymer hybrid systems for the treatment of benign prostate hyperplasia

  Ceyda Tuba Sengel-Turk

  PDF HTML

• The effect of Ginsenoside Re on neuroinflammation in an ALS animal model

  Eun Jin Yang

  PDF HTML

• Application of computer-aided drug design strategies for optimization of Anticancer activity of Phenazinamine derivatives

  Gajanan M Sonwane

  PDF HTML

• Drug design strategies in neuroinflammatory disorders

  Salvatore Cuzzocrea

  PDF HTML

• Local Infiltration Anaesthia (LIA) and novel technique for effective pain relief following elective primary hip and knee replacement-innovative study

  M Salhab, Kimpson P, Freeman J, Stewart T, Stone MH

  PDF HTML

• Glucocorticoid-sparing properties of β-blockers different selectivity for remodeling and inflammation in the bronchi in the rat model of asthma by dry insufflations

  Marina Syrczova

  PDF HTML

• Inhibitors of Icmt and GGTase-I as anti-cancer drug targets

  Nisar Ullah

  PDF HTML

• Computational modeling in investigational new drug (IND) and research medications: A case study

  Seyed Ali Sadegh Zadeh and Chandrasekhar Kambhampati

  PDF HTML

• Cytotoxicity and genotoxicity screening of 1-ethyl-3-methylimidazolium alkyl benzenesulfonate (EMIM-ABS) ionic liquids

  Hiranamayee Kandala

  PDF HTML

• Levodopa treatment strategies in Parkinsons disease: What is new?

  Yildiz Degirmenci

  PDF HTML